Canada is in the midst of negotiations over the Comprehensive Economic and Trade Agreement (CETA) with the European Union, and the multi-country Trans-Pacific Partnership (TPP). A key issue to be settled in these negotiations is intellectual property (IP) protection for pharmaceutical...

The established role of pharmaceutical products in the current health care landscape combined with increasing reports of serious and often fatal toxicity associated with these products have led to growing calls for reform of drug regulation. The growing public-private partnerships in research...

The premature cancer mortality rate has been declining in Canada, but there has been considerable variation in the rate of decline across cancer sites. I analyze the effect that pharmaceutical innovation had on premature cancer mortality in Canada during the period 2000-2011, by investigating...